Theratechnologies Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Theratechnologies Inc. with three other companies in this sector in Canada: Cardiome Pharma Corp. (2017 sales of 31.09 million Canadian Dollars [US$24.62 million] of which 100% was Pharma Product Development), Aphria Inc (20.44 million Canadian Dollars [US$16.18 million] ), and Cipher Pharmaceuticals, Inc. (52.22 million Canadian Dollars [US$41.34 million] of which 100% was Specialty Pharmaceuticals).

Sales Analysis. During the year ended November of 2017, sales at Theratechnologies Inc. were C$42.86 million (US$33.94 million). This is an increase of 15.6% versus 2016, when the company's sales were C$37.07 million. This was the third consecutive year of growth at Theratechnologies Inc..